# Project Frazier 3 Regulatory Clinical Evaluation

> **NCT03515421** · NA · COMPLETED · sponsor: **LifeScan Scotland Ltd** · enrollment: 379 (actual)

## Conditions studied

- Diabetes Mellitus
- Healthy Volunteers

## Interventions

- **DEVICE:** Frazier 3 Verio
- **DEVICE:** Frazier 3 UltraPlus

## Key facts

- **NCT ID:** NCT03515421
- **Lead sponsor:** LifeScan Scotland Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-09
- **Primary completion:** 2018-06-18
- **Final completion:** 2018-06-18
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515421, "Project Frazier 3 Regulatory Clinical Evaluation". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03515421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*